tapentadol prodrug + PF-05 (Signature Therapeutics)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nametapentadol prodrug + PF-05 (Signature Therapeutics)
Drug Alias Nametapentadol prodrug + PF-05 (PharmacoFore)PF-16 program
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor antagonistsNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporterMu opioid receptor
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSignature Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignature Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A